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Abstract. 
 
Active matrix metalloproteinases and de-
graded collagen are observed in disease states, such as 
atherosclerosis. To examine whether degraded collagen 
fragments have distinct effects on vascular smooth mus-
cle cells (SMC), collagenase-digested type I collagen 
was added to cultured human arterial SMC. After addi-
tion of collagen fragments, adherent SMC lose their fo-
cal adhesion structures and round up. Analysis of com-
ponents of the focal adhesion complex demonstrates 
rapid cleavage of the focal adhesion kinase (pp125
 
FAK
 
), 
paxillin, and talin. Cleavage is suppressed by inhibitors 
of the proteolytic enzyme, calpain I. In vitro translated 
pp125
 
FAK
 
 is a substrate for both calpain I– and II–medi-
ated processing. Mapping of the proteolytic cleavage 
fragments of pp125
 
FAK
 
 predicts a dissociation of the fo-
cal adhesion targeting (FAT) sequence and second pro-
line-rich domain from the tyrosine kinase domain and 
integrin-binding sequence. Coimmunoprecipitation 
studies conﬁrm that the ability of pp125
 
FAK
 
 to associate 
with paxillin, vinculin, and p130cas is signiﬁcantly re-
duced in SMC treated with degraded collagen frag-
ments. Further, there is a signiﬁcant reduction in the as-
sociation of intact pp125
 
FAK
 
 with the cytoskeletal 
fraction, while pp125
 
FAK
 
 cleavage fragments appear in 
the cytoplasm in SMC treated with degraded collagen 
fragments. Integrin-blocking studies indicate that inte-
grin-mediated signals are involved in degraded collagen 
induction of pp125
 
FAK
 
 cleavage. Thus, collagen frag-
ments induce distinct integrin signals that lead to initia-
tion of calpain-mediated cleavage of pp125
 
FAK
 
, paxillin, 
and talin and dissolution of the focal adhesion complex.
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E
 
XTRACELLULAR
 
 matrix (ECM)
 
1
 
 molecules regulate
cell function by acting as both structural support
and signaling mediators (Hay, 1989; Hynes, 1992).
Integration of the intracellular signaling and structural re-
sponses initiated by ECM-integrin engagement may be
mediated through the focal adhesion complex (Burridge et
al., 1988). Focal adhesions are localized to sites of integrin-
ECM adhesion (Burridge and Chrzanowska-Wodnicka,
1996). They consist of numerous, tightly associated, struc-
tural and signaling proteins and the cytoplasmic tail of
 
b
 
 integrins, which provide intracellular signal transduction
machinery but also serve as a physical link between the
ECM and the cytoskeleton (Sastry and Horwitz, 1993).
Focal adhesion kinase (pp125
 
FAK
 
) is a cytoplasmic ty-
rosine kinase that localizes to focal adhesions and may
play an important role in the integration of signals from in-
tegrins and growth factors (Hanks and Polte, 1996; Zach-
ary and Rozengurt, 1992). The pp125
 
FAK
 
 protein can be
subdivided into three functional domains: an NH
 
2
 
-termi-
nal integrin-binding domain necessary for association with
the cytoplasmic domain of 
 
b
 
1 integrin subunits (Schaller
et al., 1995), an internal kinase domain, and a COOH-ter-
minal domain consisting of two proline-rich motifs and a
focal adhesion targeting sequence required for association
with other focal adhesion proteins, including p130cas, pax-
illin, and talin (Chen et al., 1995; Hildebrand et al., 1995;
Polte and Hanks, 1995). pp125
 
FAK
 
 also contains a number
of sites of tyrosine phosphorylation involved in binding to
the SH2 domains of signaling proteins such as P-I3 kinase,
pp60
 
src
 
 and Grb2 (Schaller et al., 1994; Schlaepfer et al.,
1994; Bachelot et al., 1996). Through these protein-bind-
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1. 
 
Abbreviations used in this paper:
 
 ALLN, calpain inhibitor 1; ECL, en-
hanced chemiluminescence; ECM, extracellular matrix; FAK, focal adhe-
sion kinase; FAT, focal adhesion targeting (sequence); FRNK, pp125
 
FAK
 
-
related non-kinase; MMP, matrix metalloproteinase; pp125
 
FAK
 
, focal
adhesion kinase; RIPA, radioimmunoprecipitation assay; SMC, smooth
muscle cells; TIMP, tissue inhibitors of metalloproteinase; ZVAD-fmk,
benzyloxycarbonyl Val-Ala-Asp fluoromethyl ketone (caspase inhibitor). 
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ing domains, pp125
 
FAK
 
 plays a central role in the recruit-
ment of signaling molecules to the focal adhesion complex
and in the transduction of downstream signals derived
from integrin-ECM interactions (reviewed in Guan, 1997).
Previous studies have implicated tyrosine phosphorylation
of pp125
 
FAK
 
 as the primary mechanism whereby integrin-
ECM interactions regulate pp125
 
FAK
 
 activity and recruit-
ment of signaling molecules (Schaller and Parsons, 1995).
However, a recent study carried out on platelets proposed
a novel mechanism of pp125
 
FAK
 
 regulation, in which the
calcium-activated proteolytic enzyme calpain I induces cleav-
age of pp125
 
FAK
 
, leading to downregulation of pp125
 
FAK
 
autokinase activity and altered intracellular localization
(Cooray et al., 1996).
ECM-integrin engagement may affect numerous biologi-
cal processes in vivo, including cell participation in the de-
velopment of lesions of atherosclerosis (Thyberg et al.,
1990). Smooth muscle cells within the medial layer of nor-
mal arteries are surrounded by a dense network of intersti-
tial type I and III collagen fibers (Barnes, 1985). However,
disruption of collagen fibers during atherogenesis is thought
to occur as a result of increased activation of matrix metal-
loproteinases derived from either infiltrating macrophages
or activated SMC (Bendeck et al., 1994; Galis et al., 1994).
SMC are arrested at the G1 stage of the cell cycle in vitro on
polymerized type I collagen fibrils, whereas monomer col-
lagen supports SMC proliferation (Koyama et al., 1996).
From these studies, we hypothesized that the ECM sur-
rounding SMC in the normal media may be nonpermissive
for SMC proliferation. Degradation of the ECM during
different stages of lesion development may release SMC
from this nonpermissive state and promote SMC migra-
tion and proliferation. Previous studies have indicated that
denaturation or proteolysis of the type I collagen triple
helix may reveal cryptic RGD integrin-binding motifs
(Davis, 1992; Montgomery et al., 1994). Recent studies
also demonstrate that processing of the ECM protein
laminin 5 by matrix metalloproteinases generates frag-
ments that have different cell signaling properties from in-
tact laminin 5 (Gianelli et al., 1997). These studies raise
the possibility that fragments of degraded collagen gener-
ated within the atherosclerotic lesion may modulate SMC
behavior by possessing specific integrin signaling proper-
ties, which are distinct from those of intact native collagen
found in normal arteries.
In this study, we describe the rapid induction of calpain-
mediated cleavage of pp125
 
FAK
 
, paxillin, and talin in re-
sponse to treatment of SMC with collagenase-degraded
collagen fragments. The cleavage of pp125
 
FAK
 
, paxillin,
and talin in adherent SMC occurs in parallel with func-
tional and molecular focal adhesion disassembly and cell
rounding. We propose that calpain-mediated cleavage of
pp125
 
FAK
 
 represents a dynamic mechanism for regulating
pp125
 
FAK
 
 activity and together with paxillin and talin
cleavage promotes focal adhesion disassembly in response
to matrix degradation.
 
Materials and Methods
 
Cell Culture and Collagen Matrix Preparation
 
Human newborn arterial SMC were isolated from the thoracic aorta as
described previously (Bornfeldt et al., 1994). SMC between passages 5
and 9 were cultured on the surface or in the presence of the following col-
lagen type I preparation: polymerized collagen gels (1.0 mg/ml final con-
centration) prepared by neutralization of the collagen solution (Vitrogen
100, Collagen Corp.) with 1/6 volume of 7
 
3
 
 DME concentrate, dilution to
a final 1
 
3
 
 DME solution, and incubation at 37
 
8
 
C for 24 h. Monomer col-
lagen-coated dishes were prepared by incubating with 0.1 mg/ml of col-
lagen solution in 0.1 M acetic acid for 24 h. Monomer collagen-coated
dishes were washed twice with DME before cell seeding. Degraded type I
collagen was prepared by incubating polymerized collagen gels (prepared
as above) with 2.5 mg/ml collagenase type 1 (Worthington Biochemical
Corp.) for 30 min at 37
 
8
 
C. After digestion, collagenase activity was inhib-
ited by the addition of an equal volume of 1
 
3
 
 DME containing 2%
plasma-derived serum (Raines and Ross, 1985). Fibronectin was purified
from human plasma as previously described (Faull et al., 1994). Fibronec-
tin-coated dishes (0.625 
 
m
 
g/cm
 
2
 
) were prepared by overnight incubation at
room temperature.
 
Inhibitors and Antibodies
 
Calpain and caspase inhibition studies were performed with two inhibi-
tors: calpain inhibitor 1 (ALLN; Calbiochem-Novabiochem Corp.) and
the caspase inhibitor benzyloxycarbonyl Val-Ala-Asp fluoromethyl ke-
tone (ZVAD-fmk; Alexis Biochemicals). SMC were preincubated with
ALLN or ZVAD (100 
 
m
 
m) for 3 h or overnight before treatment with de-
graded collagen in the presence of ALLN or ZVAD. To block integrin
function, SMC were preincubated at 37
 
8
 
C for 30 min with nonblocking
(P1H6) and blocking (P1H5) Fab antibody fragments against 
 
a
 
2, blocking
anti-
 
a
 
3 Fab antibody (P1B5), blocking 
 
a
 
v
 
b
 
3 (LM609; Chemicon) at (5 
 
m
 
g/
200,000 cells) and 
 
a
 
v blocking (cyclic penRGD) and control (RGE) pep-
tides (100 
 
m
 
M) (GIBCO BRL). Monoclonal antibody supernatants for 
 
a
 
2
and 
 
a
 
3 were provided by W.G. Carter (Fred Hutchinson Cancer Research
Center, Seattle, WA). Matrix metalloproteinase inhibition studies were
performed with recombinant human tissue inhibitors of metalloproteinase
(TIMP1 and TIMP2; 3 
 
m
 
g/ml; Oncogene Research Products). Antibodies
for Western blot detection, immunoprecipitation, and immunostaining in-
cluded: 
 
2–18
 
N pp125
 
FAK
 
 and 
 
903–1058
 
C pp125
 
FAK
 
 (Santa Cruz Biotechnol-
ogy), 
 
354–534
 
N pp125
 
FAK
 
 (Transduction Laboratories), 
 
a
 
-actinin (Sigma),
p130cas, paxillin (Transduction Laboratories), talin-8d4 (Sigma), and vin-
culin (Calbiochem-Novabiochem Corp.). Anti–mouse and –rabbit peroxi-
dase-conjugated secondary antibodies were purchased from Vector Labo-
ratories Inc.
 
Immunocytochemistry
 
SMC were plated on monomeric collagen- or fibronectin-coated plastic
chamber slides for 24 h and either left untreated or treated with degraded
collagen fragments for 1–5 min. Cells were fixed in 4% paraformaldehyde,
permeabilized in 0.5% Triton X-100 in PBS and washed serially in PBS,
0.15 M glycine/PBS 
 
1
 
 0.02% NaN
 
3
 
, and PBS. Cells were blocked in 5%
normal goat serum, 0.05% Tween in PBS for 30 min and incubated with
primary antibodies to paxillin and vinculin for 1 h at room temperature
followed by several washes in PBS and subsequent incubation with FITC-
labeled secondary antibodies (Vector Laboratories Inc.). Cells were also
incubated with FITC-labeled phalloidin (Sigma). Immunostaining of cells
was analyzed by confocal microscopy.
 
Cell Lysis, Immunoblotting, and Immunoprecipitations
 
Cells were washed twice with PBS and lysed in lysis buffer (50 mM Hepes,
pH 7.5, 150 mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 1 mM DTT, 1 mM
NaF, 0.1 mM Na
 
3
 
VO
 
4
 
, 10 mM 
 
b
 
-glycerophosphate, 0.5 mM PMSF, 10 
 
m
 
g/ml
leupeptin, and 10 
 
m
 
g/ml aprotinin) for 30 min on ice. Cell lysates were
clarified by centrifugation at 27,000 
 
g
 
 for 20 min, and protein concentra-
tion was determined using the BCA protein assay (Pierce). Lysates were
separated on 10% or 7.5% SDS-PAGE; proteins were transferred to Im-
mobilon membrane (Millipore) and immunoblotted with specific antibod-
ies. All immunoblots were visualized by enhanced chemiluminescence
(ECL, Amersham Corp.). For pp125
 
FAK
 
 coimmunoprecipitation studies,
cell lysates were precleared with protein A-agarose (Santa Cruz Biotech.),
incubated with 2 
 
m
 
g of the 
 
2-18
 
N pp125
 
FAK
 
 antibody, and immunoblotted
with specific antibodies against p130cas, paxillin, and vinculin.
Triton X-100–soluble (cytoplasmic) and –insoluble (cytoskeletal) frac-
tions were prepared as previously described (Jackson et al., 1994), with
the exception of modification of Triton X-100 and radioimmunoprecipita-
tion assay (RIPA) lysis buffers. In brief, SMC were lysed in Triton X-100 
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lysis buffer (20 mM Tris-HCl, pH 7.4, 1% Triton X-100, 5 mM EGTA,
0.4 mM leupeptin, 0.2 mM Na
 
3
 
VO
 
4
 
, and 0.1 mM PMSF) for 1 h at 4
 
8
 
C. Tri-
ton X-100 insoluble and soluble extracts were separated by centrifugation
at 15,000 
 
g
 
 for 5 min. The cytoskeletal pellet was washed twice with Tri-
ton-free lysis buffer, and proteins were extracted using RIPA buffer (10 mM
Tris-HCl [pH 7.2], 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
150 mM NaCl, 2 mM EDTA, 1 mM PMSF, and 1 mM Na
 
3
 
VO
 
4
 
).
 
In Vitro Cleavage of pp125
 
FAK
 
In vitro transcription and translation of pp125
 
FAK
 
 were performed with
the TNT
 
®
 
-coupled reticulocyte lysate system (Promega) and [
 
35
 
S]me-
thionine (1,000 Ci/mmol, Amersham Corp.), according to the manufac-
turer’s instructions. The expression plasmid for chicken pp125
 
FAK
 
 was
given by J.T. Parsons (University of Virginia, Charlottesville, VA). Of the
reaction, 1/25 was used as a substrate and incubated with a range of 0.25–2
activity units of purified calpain I and calpain II (Calbiochem-Nova-
biochem Corp.) for 30 min at 30
 
8
 
C in reaction buffer (50 mM Tris-HCl,
pH 7.4, 10 mM CaCl
 
2
 
, 5 mM 
 
b
 
-mercaptoethanol, and 30 mM NaCl) in the
presence and absence of the human recombinant endogenous calpain in-
hibitor, calpstatin (30 
 
m
 
M; Calbiochem-Novabiochem Corp.). Reactions
were terminated by the addition of 4
 
3 
 
SDS sample buffer. Common mo-
lecular mass standards (Bio-Rad Laboratories) were used to determine Rf
values and proteolytic fragment size for both in vitro and cellular
pp125
 
FAK
 
 cleavage analysis.
 
Collagen Radiolabeling and Degradation Assay
 
Vitrogen (Collagen Corp.) concentration was adjusted to 1 mg/ml and
neutralized after dialysis against 10 mM borate, 0.2 M CaCl
 
2
 
, pH 8. The
vitrogen solution was then radiolabeled by acetylation with [
 
3
 
H]acetic an-
hydride (NEN Life Science) as described previously (Mookhtiar et al.,
1986). 
 
3
 
H-labeled collagen degradation was assayed by modification of a
previously described procedure (Aimes and Quigley, 1995). In brief, an al-
iquot of radiolabeled vitrogen was used to generate polymerized fibrillar
collagen gels, as described above. SMC were cultured on the labeled poly-
merized collagen, and at subsequent time points after cell seeding culture
supernatants were analyzed for degraded 
 
3
 
H-labeled collagen fragments
by liquid scintillation spectroscopy.
 
Zymography
 
Cell lysates were prepared in lysis buffer as described above and serum-
free conditioned media was collected from SMC cultures. Samples were
prepared in nondenaturing loading buffer and separated on 10% SDS–
polyacrylamide gel impregnated with 1 mg/ml gelatin. After electrophore-
sis, gels were washed twice in 2.5% Triton X-100 for 30 min, briefly rinsed
with water, and incubated for 24 h at 37
 
8
 
C in collagenase buffer (50 mM
Tris-HCl buffer, pH 7.5, 200 mM NaCl, and 10 mM CaCl
 
2
 
). Gels were sub-
sequently fixed and stained in Coomassie blue fixative solution (50%
methanol and 10% acetic acid containing 0.25% Coomassie blue R250).
 
Results
 
Degraded Collagen Fragments Induce Cell Rounding 
and Promote Cleavage of pp125
 
FAK
 
Human arterial SMC cultured on polymerized type I col-
lagen fibrils are arrested in the G1 phase of the cell cycle
and do not respond to growth factor stimulation, whereas
SMC on monomeric type I collagen proliferate in response
to growth factors (Koyama et al., 1996). We hypothesized
Figure 1. SMC spreading and
substrate attachment are im-
paired after treatment with
degraded collagen. Human
arterial SMC were cultured
on monomeric collagen (A–
C, G–J) or fibronectin (D–F)
for 24 h before addition of de-
graded collagen fragments.
SMC shape and substrate at-
tachment 5 and 30 min after
addition of degraded collagen
were evaluated by phase-con-
trast microscopy (A–F). 5
min after treatment, SMC
cultured on monomeric col-
lagen were fixed and immu-
nostained with antibodies to
paxillin (G and H) and vincu-
lin (I and J) and examined
by confocal microscopy. Bars:
20 mm. 
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that matrix alteration or degradation may be necessary to
release cells from a nonpermissive state, such as culture on
polymerized collagen. To test whether degraded type I
collagen has unique properties, we added degraded col-
lagen to SMC that had been plated on monomeric col-
lagen or fibronectin for 24 h. Within 5 min after addition
of degraded collagen, the SMC round up but remain
loosely attached (Fig. 1, B and E). This cell rounding is re-
versible; after incubation with degraded collagen for 24 h,
SMC attach and spread if the degraded collagen is re-
moved and the cells are plated on fresh monomeric col-
lagen or fibronectin-coated dishes (results not shown).
To evaluate effects on focal adhesions, we immu-
nostained SMC cultures with antibodies against paxillin
(Fig. 1, G and H) and vinculin (Fig. 1, I and J). On mono-
meric collagen, SMC exhibit abundant vinculin- and paxil-
lin-containing focal adhesion structures (Fig. 1, G and I),
while these structures are almost totally absent when SMC
are treated for only 5 min with degraded collagen (Fig. 1,
H and J). The loss of focal adhesions is also reversible, and
focal adhesions recover within 3 h after removal of de-
graded collagen and replating of SMC on fresh monomeric
collagen (data not shown).
 
Degraded Collagen Promotes Calpain-mediated 
Cleavage of pp125
 
FAK
 
 in Smooth Muscle Cells
 
Because degraded type I collagen reversibly alters cell
spreading and focal adhesion formation, we asked whether
it alters a major component of focal adhesions, focal adhe-
sion kinase (pp125
 
FAK
 
). Incubation with degraded col-
lagen (1 mg/ml concentration) rapidly induces pp125
 
FAK
 
processing, resulting in a significant reduction in the levels
of native pp125
 
FAK
 
, as monitored by Western analysis with
a polyclonal antibody to the NH
 
2
 
 terminus of pp125
 
FAK
 
(Fig. 2 A). This reduction in native pp125
 
FAK
 
 is accompa-
nied by an increase in levels of 90-, 50-, and 42-kD
bands. By immunoblotting the same lysates with an anti-
body to pp125
 
FAK
 
 directed against residues 354–534 (see
Fig. 4 B), we detect 90- and 40-kD fragments (Fig. 2
B). Using a polyclonal antibody against the COOH ter-
minus of pp125
 
FAK
 
, we identify a cleaved 35-kD fragment
(Fig. 2 C). This cleavage of pp125
 
FAK
 
 is reversible, and na-
tive pp125
 
FAK
 
 is restored to maximal levels within 3 h
when the degraded collagen is removed and the SMC are
replated on fresh monomeric collagen (data not shown).
The cleavage of pp125
 
FAK
 
 is also specific for treatment
with degraded collagen, and is not observed upon addition
of BSA (Fig. 3 A) or laminin treated with collagenase (re-
sults not shown).
pp125
 
FAK
 
 cleavage mediated by caspases has been dem-
onstrated in Jurkat T cells (Wen et al., 1997) and endothe-
lial cells (Levkau et al., 1998). Cleavage of pp125
 
FAK
 
 has
also been observed in platelets, where it is mediated by the
calcium-activated protease calpain I, which results in pro-
teolytic fragments of 90, 45, and 40 kD (Cooray et al.,
1996), similar in size to those observed when SMC are
treated with degraded collagen. To determine whether
calpain and/or caspases are responsible for pp125
 
FAK
 
 pro-
cessing, we treated SMC with degraded collagen in the
presence of the calpain inhibitor ALLN (100 
 
m
 
M) or the
broad caspase inhibitor ZVAD (100 
 
m
 
M). As shown in
Fig. 3, inhibition of calpain partially reduces processing of
native pp125
 
FAK
 
, whereas the caspase inhibitor (ZVAD)
has no influence on pp125
 
FAK
 
 processing.
To identify which calpain(s) is capable of cleaving
pp125
 
FAK
 
, we incubated in vitro translated pp125
 
FAK
 
 with
purified calpain I or calpain II. As shown in Fig. 4 A, both
calpain I and II induce dose-dependent processing of
pp125
 
FAK
 
 to 90-, 50-, 40-, and 35-kD fragments. The pro-
teolytic activity of either calpain I or II can be blocked by
incubation with the specific endogenous calpain inhibitor
calpstatin (30 
 
m
 
M). The size of the proteolytic pp125
 
FAK
 
fragments obtained in vitro correlates with the proteolytic
cleavage of pp125
 
FAK
 
, observed when SMC are treated
with degraded collagen fragments (Fig. 2). The putative
proteolytic fragments are illustrated in Fig. 4 B with the
epitopes of pp125
 
FAK
 
 antibodies used to characterize the
cleavage.
Figure 2. Cleavage of pp125FAK in response to treatment with de-
graded type I collagen. SMC were cultured on monomeric col-
lagen (M) or in suspension (S) for 30 min in the presence or ab-
sence of degraded type I collagen fragments (1 Deg. Col.). Cell
lysates were prepared, separated on SDS-PAGE (10% separat-
ing gel), transferred to Immobilon membranes, and immunoblot-
ted with three antibodies against pp125FAK: (A) a polyclonal anti-
body to residues 2–18 at the NH2 terminus (2–18N); (B) a
monoclonal antibody to residues 354–534 (354–534N); and (C) a
polyclonal antibody to residues 903–1052 at the COOH terminus
(903–1052C). Arrowheads indicate approximate molecular masses
of proteolytic cleavage fragments of pp125FAK determined from
molecular mass standards used to calculate Rf values.
Figure 3. pp125FAK cleavage is blocked by calpain inhibition. (A)
SMC in suspension were incubated, with collagenase degraded
collagen (1Deg. Col.) or degraded BSA (1 Deg. BSA) for 30
min. Cell lysates were separated by SDS-PAGE transferred to an
Immobilon membrane and immunoblotted with 2–18N-pp125FAK
antibody. (B) SMC cultured on monomeric collagen (M) or in
suspension (S) were exposed to degraded collagen (1 Deg. Col.)
for 30 min in the presence or absence of inhibitors of calpains
(ALLN, 100 mM) and caspases (ZVAD, 100 mM). Total cell ly-
sates were prepared, separated by SDS-PAGE, transferred to a
membrane, and immunoblotted with 2–18N-pp125FAK antibody.Carragher et al. pp125FAK Cleavage and Focal Adhesion Disassembly 623
a2b1 Integrins Interact with Degraded Collagen to 
Induce pp125FAK Cleavage
We asked whether the ability of degraded collagen to pro-
mote pp125FAK cleavage was mediated through ligation
with cell surface integrin receptors. SMC cultured on fi-
bronectin were preincubated with Fab fragments of block-
ing (P1H5) or nonblocking (P1H6) antibodies against the
a2 integrin subunit, blocking a3 integrin subunit antibody
(P1D6), blocking avb3 antibody (LM609), or av-blocking
(cyclic RGD) or control (RGE) peptides, followed by 30
min incubation in the presence of degraded collagen frag-
ments (0.25 mg/ml). Preincubation with nonblocking anti-
a2 Fab fragments, a blocking anti-a3 Fab, blocking anti-
avb3, or RGE peptide did not prevent pp125FAK cleavage.
However, when degraded collagen was added to SMC pre-
incubated with either blocking anti-a2 Fab, cyclic RGD
peptide, or a2 Fab and cyclic RGD peptide in combina-
tion, the induction of pp125FAK cleavage was suppressed
(Fig. 5 A). Changes in pp125FAK cleavage with integrin
blockade were quantified by densitometric scanning of
both native 125 kD pp125FAK and the 90-kD cleavage frag-
ment. Densitometry values from three separate experi-
ments were combined and are shown in Fig. 5 B. Asterisks
indicate significant difference from control 1 degraded
collagen (P , 0.05 by Student’s t test). Although suppres-
sion of pp125FAK cleavage by preincubation with av-block-
ing cyclic RGD peptide is a consistent observation, statisti-
Figure 4. Calpain I and II cleave pp125FAK in vitro into multiple
fragments that separate domains. (A) In vitro translated
pp125FAK labeled with [35S]methionine was used as a substrate
and incubated with increasing concentrations of purified calpain
I and calpain II enzyme (0.25–2 units), and cleavage fragments
were evaluated by SDS-PAGE and autoradiography. Recombi-
nant calpain inhibitor calpstatin was added to reactions with 1
unit calpain I and calpain II. The mobility of molecular mass
standards (201 kD, myosin; 115 kD, b-galactosidase; 81 kD, bo-
vine serum albumin; 43 kD, carbonic anhydrase; 33 kD, soybean
trypsin inhibitor [Bio-Rad Laboratories]) used to determine Rf
values and proteolytic fragment size (arrows) are indicated on
the right. (B) The protein-binding domains of pp125FAK and
FRNK are indicated, and putative cleavage fragments resulting
from calpain cleavage are shown. Epitopes of pp125FAK-specific
antibodies used to evaluate the cleavage fragments are also indi-
cated.
Figure 5. Interaction of degraded collagen with a2-containing in-
tegrins promotes pp125FAK cleavage. (A) SMC adherent to fi-
bronectin were preincubated for 30 min with Fab fragments (5
mg/200,000 cells) of a nonblocking a2 antibody (P1H6; NBa2)
and a blocking anti-a2 integrin antibody (P1H5, Ba2); blocking
anti-a3 antibody (P1B5, Ba3); blocking avb3 (LM609, Bavb3);
and av-blocking (cyclic RGD, CRGD) and control (RGE) pep-
tides (100 mM) for 30 min. Cells were subsequently incubated
with degraded collagen for 30 min. Control samples consist of
cells on fibronectin incubated with degraded collagen, without
prior antibody preincubation (control 1 Degraded Collagen), or
cells on fibronectin not treated with either antibody preincuba-
tion or degraded collagen (control 2 Deg. Col.). Total cell lysates
were prepared, separated by SDS-PAGE, transferred to a mem-
brane, and immunoblotted with 2–18N-pp125FAK antibody. (B)
The consequence of integrin blocking on degraded collagen in-
duction of pp125FAK cleavage was quantified by performing den-
sitometry on Western blots representing three separate experi-
ments. Data for intact 125-kD pp125FAK and the 90-kD fragment
are shown. *P , 0.05 by Student’s t test.The Journal of Cell Biology, Volume 147, 1999 624
cal analysis of three quantified experiments reveal that
this effect is not quite significant. The blocking anti-avb3
is ineffective because the SMC do not express detectable
avb3 (Skinner et al., 1994). These results suggest that a2-
and to some extent, av-containing integrins may contrib-
ute to the induction of pp125FAK cleavage stimulated by
degraded collagen fragments.
Degraded Collagen Promotes Calpain-mediated 
Cleavage of Paxillin and Talin but Not a-Actinin
Three other focal adhesion proteins, paxillin, talin, and
a-actinin, have been shown to be substrates for calpain
(Yamaguchi et al., 1994; Selliah et al., 1996; Schoen-
waelder et al., 1997). We asked whether they are also
cleaved in SMC exposed to degraded collagen. Native pax-
illin levels (68 kD) are slightly reduced in SMC cultured
with degraded collagen, and a 55-kD band appears (Fig. 6
A). Inhibition of calpain (ALLN, 100 mM) prevents pro-
cessing to the 55-kD paxillin fragment, whereas caspase in-
hibition with ZVAD (100 mM) has no effect. Similarly na-
tive talin (230 kD) also appears to be proteolytically
cleaved giving rise to a 190-kD fragment in SMC treated
with degraded collagen (Fig. 6 B). The generation of a
190-kD cleavage fragment of talin is identical in size to a
previously identified calpain-mediated cleavage product
of talin (Schoenwaelder et al., 1997). Inhibition of calpain
but not caspase activity suppresses talin cleavage (Fig. 6
B). In contrast to paxillin, talin and pp125FAK, a-actinin is
not processed in response to degraded collagen (Fig. 6 C),
nor is actin, another known substrate of calpain (data not
shown).
Degraded Collagen-induced Cleavage of pp125FAK 
Decreases Its Interaction with Components of the Focal 
Adhesion Complex and Alters Its
Intracellular Localization
The COOH-terminal cleavage fragment of pp125FAK (35 kD)
contains the focal adhesion targeting (FAT) sequence and
second proline-rich domain (p2) of pp125FAK, sites in-
volved in pp125FAK interaction with other focal adhesion
proteins, such as p130cas, paxillin, and vinculin (Fig. 4 B).
We asked whether the ability of pp125FAK to associate
with other focal adhesion signaling molecules is altered in
SMC after treatment with degraded collagen. Coimmuno-
precipitation studies using the 2–18NH2-terminal pp125FAK
antibody demonstrate a significant reduction in the associ-
ation of paxillin, vinculin, and p130cas with pp125FAK in
SMC cultured with degraded collagen compared with cells
on monomeric collagen (Fig. 7). Control coimmunoprecip-
itation assays using a normal rabbit IgG were performed
in parallel with pp125FAK immunoprecipitations, and rab-
bit IgG did not associate with paxillin, vinculin, or p130cas
in either untreated or degraded collagen-treated SMC
samples (results not shown).
The subcellular localization of pp125FAK between cy-
toplasmic and cytoskeletal fractions is also altered in
SMC treated with degraded collagen (Fig. 8). Significantly
less native pp125FAK is in the cytoskeletal fraction, and
the NH2-terminal proteolytic fragments of pp125FAK are
predominantly found in the cytoplasmic fraction. Levels
of native pp125FAK in the cytoplasmic fraction are
only slightly reduced in response to treatment with de-
graded collagen, suggesting that cytoskeleton-associated
pp125FAK may be more sensitive to calpain-mediated pro-
cessing.
Pretreatment with Calpain Inhibitor Suppresses 
Degraded Collagen-induced Cell Rounding and 
Disassembly of Actin Cytoskeleton
To directly test the role of calpain activity in focal adhe-
sion disassembly and cell rounding induced by degraded
collagen, SMC cultured on fibronectin were preincubated
with or without calpain inhibitor 1 (ALLN, 100 mM) for 18 h
before addition of degraded collagen (0.25 mg/ml). Immu-
nostaining with antibodies against paxillin (Fig. 9, A–C)
and FITC-labeled phalloidin (Fig. 9, D–F) demonstrate
that, in the absence of calpain inhibition, SMC round up
and retain limited numbers of focal adhesions one minute
after the addition of degraded collagen (Fig. 9 A). In con-
Figure 6. Degraded collagen induces calpain-mediated cleavage
of paxillin and talin but not a-actinin. SMC cultured on mono-
meric collagen (M) or in suspension (S) were exposed to de-
graded collagen (1 Deg. Col.) for 30 min in the presence (A and
B) or absence (A–C) of inhibitors of calpains (ALLN, 100 mM)
and caspases (ZVAD, 100 mM). Total cell lysates were prepared,
separated by SDS-PAGE, transferred to Immobilon membrane,
and immunoblotted with (A) anti-paxillin antibody, (B) anti-talin
antibody, or (C) anti–a-actinin antibody.
Figure 7. Decreased association of cleaved pp125FAK with com-
ponents of the focal adhesion complex. pp125FAK was immuno-
precipitated from SMC on monomeric collagen incubated for 30
min in the absence (2) or presence (1) of degraded collagen
fragments. pp125FAK-associated paxillin, vinculin, and p130cas
were detected after SDS-PAGE, transferred to a membrane, and
immunoblotted (left). Direct Western blots of the same total cell
lysates used for immunoprecipitation are shown on the right.Carragher et al. pp125FAK Cleavage and Focal Adhesion Disassembly 625
trast, SMC preincubated with the calpain inhibitor round
up to a lesser extent after incubation with degraded col-
lagen, and many of these cells contain more focal adhe-
sions than cells not treated with calpain inhibitor (Fig. 9, B
and C). SMC incubated with degraded collagen in the ab-
sence of calpain inhibition do not maintain organized
stress fibers (Fig. 9 D), whereas cells preincubated with
the calpain inhibitor retain organized actin stress fibers
and a spread morphology after treatment with degraded
collagen (Fig. 9, E and F).
Prolonged Culture of SMC on Polymerized Collagen 
Results in Increased Matrix Metalloproteinase (MMP) 
Activity, Collagen Degradation, and Calpain-mediated 
Cleavage of pp125FAK
Culture of cells, including SMC, for extended periods on
polymerized collagen or three-dimensional matrices, is as-
sociated with gradual dissolution of the matrix mediated
by induction of metalloproteinase activity (Riikonen et al.,
1995; Sudbeck et al., 1997). Therefore, we asked whether
extended culture of SMC on polymerized collagen is as-
sociated with collagen breakdown and alterations in
pp125FAK. Using 3H-labeled polymerized collagen, we
monitored the release of collagen fragments at sequential
time points after addition of SMC. Collagen degradation is
observed as early as 6 h after plating on polymerized col-
lagen, and increases at subsequent time points (Fig. 10 A).
Evaluation of pp125FAK demonstrates cleavage fragments
as early as 18 h after plating on polymerized collagen
(Fig. 10 B), which increases with time. The cleavage of
pp125FAK on polymerized collagen can be significantly
suppressed by incubation with the calpain inhibitor ALLN
(100 mM) (Fig. 10 C). Calpain-mediated cleavage of paxil-
lin and talin can also be observed in response to long-term
culture of SMC on polymerized collagen (results not
shown).
We hypothesized that the pp125FAK cleavage observed
when SMC are cultured on polymerized collagen may be
initiated as a result of generation of degraded collagen
fragments from an induction of endogenous SMC MMP
activity. Gelatin zymography demonstrates that pro and
active forms of MMP2 are increased in SMC cultured on
polymerized collagen as early as 6 h after plating (Fig. 10
D). Western blotting of cell lysates also demonstrates sig-
nificant increases in intracellular levels of both MMP1 and
MMP2 when SMC are cultured on polymerized collagen
(data not shown). Addition of recombinant TIMP1 and
Figure 8. Intracellular translo-
cation of pp125FAK cleavage
fragments to the cytoplasm.
SMC cultured on monomeric
collagen in the presence (1) or
absence (2) of degraded col-
lagen (Deg. Col.) fragments were lysed with Triton X-100 lysis
buffer and fractionated into Triton X-100–soluble (cytoplasmic)
and –insoluble (cytoskeletal) extracts. Extracts were then sepa-
rated by SDS-PAGE, transferred to a membrane, and immuno-
blotted with 2-18N-pp125FAK antibodies.
Figure 9. Preincubation with calpain inhibitor suppresses loss of substrate attachment and cell rounding induced by degraded collagen.
Human arterial SMC were cultured on fibronectin in the absence (A and D) or presence (B, C, E, and F) of 100 mM calpain inhibitor
(ALLN) for 18 h. Degraded collagen was then added to these cultures. 1 and 5 min after the addition of degraded collagen, SMC were
fixed and immunostained with antibodies to paxillin (A–C) or FITC-labeled phalloidin (D–F) and examined by confocal microscopy.
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TIMP2 (3 mg/ml) to SMC cultured on polymerized col-
lagen for 24 h significantly reduces both the induction of
MMP2 activity as determined by gelatin zymography (Fig.
11 A) and subsequent degradation of 3H-labeled polymer-
ized collagen (data not shown). Western blotting of total
cell lysates demonstrates that inhibition of MMP activity
and collagen degradation by TIMP1 and TIMP2 is accom-
panied by a significant reduction in the extent of pp125FAK
cleavage (Fig. 11 B).
Discussion
Matrix Proteolysis Exposes Cryptic Sites with
Distinct Activities
The possibility that structural changes in the ECM may be
necessary for cell migration during tissue remodeling and
tumor invasion is supported by two examples of matrix
degradation products promoting distinct migratory re-
sponses. MMP2 digestion of laminin 5 confers unique sig-
naling properties that promote cell migration, which are
not possessed by native laminin 5 (Gianelli et al., 1997).
MMP2 cleavage of the laminin 5 g2 chain exposes a cryptic
promigratory site on laminin 5. This altered form of lami-
nin 5 is found in tumors and in tissues undergoing remod-
eling, but not in quiescent tissues. It has also been shown
that thrombin cleavage of osteopontin enhances its hapto-
tactic activity (Senger and Perruzzi, 1996), and the NH2-
terminal cleavage fragment contains a cryptic adhesive se-
quence recognized by a9b1 integrin (Smith et al., 1996).
The studies presented in this report demonstrate unique
signaling properties of degraded collagen primarily medi-
ated through the integrin a2b1 that rapidly promotes focal
adhesion disassembly and cell rounding. Previous work
has proposed that denaturation or metalloproteinase deg-
radation of collagen reveals cryptic RGD integrin-binding
motifs (Davis, 1992; Montgomery et al., 1994). MMP deg-
radation of collagen differentially affects a2b1 binding to
the collagen fragments (Messent et al., 1998) and reveals a
cryptic b3 integrin binding motif, which induces specific
integrin-signaling events in SMC, resulting in increased te-
nascin-C expression (Jones et al., 1997). In our studies, the
molecular changes mediated by the interaction with de-
graded collagen fragments are not mimicked by RGD
peptides, nor mediated by avb3. The effects of degraded
collagen are independent of the substrate (and integrins)
involved in cell adhesion.
Rapid and Selective Cleavage of Focal Adhesion 
Components by Calpain after Stimulation by Degraded 
Collagen Fragments
Studies have postulated that limited proteolysis of compo-
nents of the focal adhesion complex by proteolytic en-
zymes is a potential mediator for focal adhesion disas-
sembly (Beckerle et al., 1987; Huttenlocher et al., 1997).
Particularly interesting candidate enzymes are the cal-
pains, a family of intracellular, calcium-activated cysteine
proteases, consisting of two ubiquitously expressed iso-
zymes, calpain I and II (reviewed in Molanari and Ca-
rafoli, 1997). Calpains are localized to sites of focal adhe-
sions in several cell types (Beckerle et al., 1987), and have
also been demonstrated to cleave a number of focal adhe-
sion proteins in platelets or in vitro, including pp125FAK,
pp60 src, paxillin, talin, actin, and a-actinin (Yoshida et al.,
1984; Beckerle et al., 1987; Oda et al., 1993; Yamaguchi
et al., 1994; Cooray et al., 1996; Selliah et al., 1996). How-
ever, a direct link between calpain-mediated proteolytic
activity and disassembly of focal adhesion complexes in
adherent cell populations has not been established.
In this study, we demonstrate that proteolytic cleavage
Figure 10. Increased endogenous SMC MMP activity, generation
of degraded collagen fragments, and pp125FAK cleavage in re-
sponse to culture on polymerized collagen. (A) Time course of
release of 3H-labeled collagen fragments into culture media of
SMC plated on 3H-labeled polymerized collagen. (B) Time
course of pp125FAK cleavage in response to culture on polymer-
ized collagen. (C) Protein extracts from SMC plated on polymer-
ized collagen for 24 h in the presence of the calpain inhibitor
(ALLN, 100 mM) or the caspase inhibitor (ZVAD, 100 mM) were
separated by SDS-PAGE, transferred to a membrane, and im-
munoblotted with antibodies to 2–18N-pp125FAK. (D) Gelatin zy-
mography of serum-free conditioned media from SMC cultured
on polymerized collagen at sequential time points after plating
on polymerized collagen.
Figure 11. Inhibition of endogenous SMC MMP activity and col-
lagen degradation by TIMP1 and TIMP2 suppresses cleavage of
pp125FAK. (A) MMP activity was evaluated in serum-free condi-
tioned media from SMC cultured for 24 h on monomeric (M) or
polymerized (P) collagen in the absence or presence of 3 mg/ml
TIMP1 (P1TIMP1) or TIMP2 (P1TIMP2). (B) pp125FAK cleav-
age was monitored in total cell lysates from SMC cultured for 24 h
on monomeric (M) or polymerized (P) collagen in the absence or
presence of 3 mg/ml TIMP1 (P1TIMP1) or TIMP2 (P1TIMP2).
Cell lysates were separated by SDS-PAGE, transferred to a
membrane, and immunoblotted with the 2–18N-pp125FAK anti-
body.Carragher et al. pp125FAK Cleavage and Focal Adhesion Disassembly 627
of pp125FAK, paxillin, and talin is rapidly induced in adher-
ent vascular SMC treated with degraded collagen frag-
ments, and can be observed in longer term SMC cultures
on polymerized collagen after MMP induction and the
endogenous generation of degraded collagen fragments.
Calpain inhibitor studies and in vitro cleavage assays indi-
cate that pp125FAK, paxillin, and talin cleavage is mediated
by calpain. Cleavage of other focal adhesion proteins, in-
cluding known calpain substrates, such as a-actinin and ac-
tin is not observed, indicating that calpain proteolysis in-
duced by degraded collagen is fairly selective for the focal
adhesion components pp125FAK, paxillin, and talin. Our
kinetic studies demonstrate that calpain proteolysis of
pp125FAK, paxillin, and talin is observed within 5 min after
addition of degraded collagen and occurs in parallel with
focal adhesion disassembly and loss of cell attachment.
The mechanisms that regulate calpain proteolytic ac-
tivity in vivo are still poorly understood. Studies have
proposed that translocation of calpain to the plasma
membrane and focal adhesion sites promotes activity in
response to elevated calcium (Molanari and Carafoli,
1997). Integrin ligation with ECM ligands increases intra-
cellular calcium levels (Jaconi et al., 1991), and rapid initi-
ation of calpain-mediated cleavage of substrates is ob-
served in response to integrin aIIbb3 ligation on platelets
(Fox et al., 1993; Inomata et al., 1996; Schoenwaelder et al.,
1997). The rapid kinetics of calpain-mediated cleavage of
pp125FAK, paxillin, and talin that we observe in SMC in re-
sponse to exposure to degraded collagen fragments is con-
sistent with the time course of integrin-mediated calpain
activation observed previously (Cooray et al., 1996; In-
omata et al., 1996). Our integrin-blocking studies further
suggest that initiation of pp125FAK cleavage is at least par-
tially dependent on the association of the collagen frag-
ments with a2- and possibly also av-containing integrins.
This raises the possibility that degraded collagen frag-
ments possess specific integrin-signaling properties, in-
cluding initiation of calpain activation. However, the pre-
cise downstream signaling mechanisms responsible for
initiating calpain cleavage of pp125FAK, paxillin, and talin
remain to be elucidated.
pp125FAK, a Critical Regulator of Focal Adhesion 
Turnover, Is Functionally Modulated by
Calpain Cleavage
Numerous studies have established pp125FAK phosphory-
lation as a key step in regulating focal adhesion turnover
(Burridge et al., 1992; Schaller et al., 1992). Autophosphor-
ylation of pp125FAK on tyrosine 397 generates a high affin-
ity binding site for the src family kinases (Schaller et al.,
1994; Polte and Hanks, 1995). Formation of a pp125FAK/src
signaling complex enhances the catalytic activity of both
pp125FAK and src and recruitment of other focal adhesion
proteins, further promoting assembly of the focal adhesion
signaling complex (Schlaepfer et al., 1994; Polte and
Hanks, 1997). Our studies suggested that calpain-medi-
ated cleavage of pp125FAK (Fig. 4 B) should dissociate the
COOH-terminal focal adhesion targeting sequence (FAT)
and second proline-rich domain from the NH2-terminal
catalytic kinase and integrin binding domains. Further, we
demonstrate that calpain cleavage of pp125FAK induced by
degraded collagen impairs the ability of pp125FAK to func-
tion as an adapter protein and to associate with paxillin,
p130cas, and vinculin. pp125FAK cleavage also results in
decreased levels of native pp125FAK associated with the cy-
toskeletal fraction and accumulation of NH2-terminal
cleavage fragments in the cytoplasmic fraction. This trans-
location of NH2-terminal fragments to the cytoplasm is
most likely a consequence of cleavage of the COOH-ter-
minal FAT sequence and second proline-rich domain,
which are required for localization of pp125FAK to focal
adhesion sites (Hildebrand et al., 1993; Harte et al., 1996;
Polte and Hanks, 1997). Thus, intracellular translocation
of pp125FAK, combined with impaired ability to associate
with and recruit other focal adhesion proteins, strongly
suggests that calpain cleavage represents an important
mechanism for regulating pp125FAK activity and focal ad-
hesion disassembly.
Previous studies suggest that pp125FAK activity may also
be regulated by expression of an alternatively spliced form
called pp125FAK-related non-kinase (FRNK) (Schaller et al.,
1993). FRNK is a truncated 41-kD protein identical to the
COOH-terminal domain of pp125FAK. It is not catalyti-
cally active because it lacks the kinase domain, but local-
izes to focal adhesions through protein associations medi-
ated by the COOH-terminal proline-rich domains and
FAT sequence (Schaller et al., 1993). Previous studies sug-
gest FRNK may regulate pp125FAK activity by acting as a
competitive inhibitor (Richardson and Parsons, 1996).
Our results demonstrate that calpain cleavage of pp125FAK
generates a 35-kD COOH-terminal fragment consisting of
the COOH-terminal FAT sequence and second proline-
rich domain and thus is structurally similar to FRNK. Due
to very low levels of the 35-kD COOH-terminal fragment,
we have been unable to detect whether it localizes to the
cytoskeletal fraction or is associated with other focal adhe-
sion proteins, such as paxillin. The domain structure of the
35-kD COOH-terminal fragment indicates that it has the
potential to act as a competitive inhibitor of pp125FAK, and
further contribute to disassembly of focal adhesions that
accompanies calpain cleavage of pp125FAK. However, its
effectiveness in such a role would depend on the mainte-
nance of this fragment at high levels within focal adhesion
sites.
Tyrosine phosphorylation of pp125FAK is not required
for focal adhesion assembly and cell spreading in response
to SMC adhesion to a fibronectin substrate (Wilson et al.,
1995). This is consistent with our studies, which demon-
strate that, with adhesion of SMC to distinct collagen or fi-
bronectin substrates, there is no significant regulation of
pp125FAK tyrosine phosphorylation. We, therefore, pro-
pose that, under certain conditions, the primary mecha-
nism for regulating pp125FAK activity and focal adhesion
assembly in SMC is mediated through calpain-dependent
proteolytic processing, rather than tyrosine phosphoryla-
tion. The calpain-mediated proteolysis impairs recruit-
ment of other signaling proteins, decreases association
with the cytoskeletal fraction, and generates fragments
structurally similar to FRNK that may further contribute
to focal adhesion disassembly by acting as competitive in-
hibitors of pp125FAK.
Our studies demonstrate that pretreatment of SMC with
a calpain inhibitor before incubation with degraded col-The Journal of Cell Biology, Volume 147, 1999 628
lagen fragments suppresses the cell rounding and loss of
substrate attachment. The influence of calpain inhibition
on focal adhesion disassembly is less clear, as many of the
weakly attached SMC, after treatment with degraded col-
lagen, are lost during immunostaining, and only the most
adherent cells remain attached and are evaluated by con-
focal microscopy. However, results presented in this study
indicate that pretreatment with calpain inhibitors before
addition of degraded collagen appears to enhance the
number of focal adhesion structures, compared with cells
not pretreated with the calpain inhibitor. More signifi-
cantly, calpain inhibition maintains substrate anchorage, a
spread morphology, and organized actin stress fibers in all
cells incubated with degraded collagen fragments. These
results further implicate calpain cleavage of pp125FAK,
paxillin, and talin in promoting focal adhesion disassembly
and cell rounding induced by degraded collagen. Our data
are also consistent with previous studies demonstrating
that proteolytic cleavage of pp125FAK occurs in parallel
with cell rounding and loss of substrate attachment (Fin-
cham et al., 1995; Crouch et al., 1996).
Our studies have focused primarily on the influence
calpain cleavage has on pp125FAK function and focal adhe-
sion integrity. However, calpain cleavage of paxillin and
talin is also likely to have significant consequences on fo-
cal adhesion complexes and may contribute to disassembly
of focal adhesions observed when SMC are treated with
degraded collagen fragments.
In Vivo Implications of Calpain Dissolution of SMC 
Focal Adhesions in Response to Increased MMP 
Activity and Collagen Degradation
Focal adhesions are dynamic structures that are assembled
and disassembled at different stages in the cell cycle, indi-
cating their possible involvement in regulation of cell pro-
liferation (David-Pfeuty and Singer, 1980; Herman and
Pledger, 1985). It has also been proposed that focal adhe-
sion assembly and disassembly control cell migration by
regulating attachment to the substratum at the leading
edge with detachment from the posterior end of the cell
(Huttenlocher et al., 1995). Cells derived from pp125FAK2/2
embryos exhibit a reduced capacity for cell migration and
have more focal adhesions than pp125FAK1 cells (Ilic et al.,
1995). Thus, pp125FAK may play a critical role in the regu-
lation of focal adhesion turnover and cell migration.
During the development of atherosclerotic and res-
tenotic lesions, the ECM surrounding SMC is modified by
increased MMP activity derived from both vascular SMC
and inflammatory monocytes (Bendeck et al., 1994; Galis
et al., 1994). Modulation of the vascular ECM may con-
tribute to transition of SMC to a “synthetic” phenotype,
which results in enhanced SMC proliferation, migration,
and lesion progression (Thyberg et al., 1990; Cheng et al.,
1998). Our demonstration that degraded collagen frag-
ments promote calpain-mediated disassembly of SMC fo-
cal adhesions suggests the possibility that, in localized sites
of MMP expression, SMC anchorage to the surrounding
ECM may be disrupted, thereby promoting their migra-
tion and invasion into the arterial intima. Loss of focal ad-
hesion contacts with the surrounding ECM may contribute
to enhanced SMC proliferation by releasing SMC from a
nonpermissive matrix environment, such as polymerized
collagen fibrils (Pauly et al., 1994; Koyama et al., 1996).
In conclusion, our results characterize an alternative to
phosphorylation of pp125FAK for regulating pp125FAK ac-
tivity and focal adhesion assembly in a viable adherent cell
population, one dependent on calpain-mediated cleavage
of pp125FAK, paxillin, and talin. We further demonstrate
that degraded collagen fragments initiate this cleavage
through integrin signals distinct from those of native col-
lagen.
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